Table of Contents
Following the patent cliff in 2011, the pharmaceutical industry is in a state of flux. Blockbuster drugs which generated consistent double digit growth for Big Pharma have expired, and now the industry is turning to drastic business models to maximise their revenues. Water is a core business for the pharmaceutical industry, and these developments will ultimately have a knock-on effect on the water for pharmaceuticals market.
This GWI Analysts' Report is an essential tool for any water company working within the sector - helping you to minimise the effects that these developments have on your business and maintaining success in the industry. In 50 pages, this report will analyse the changes in market dynamics and procurement processes, helping you win bids. The report pinpoints the key areas of opportunity and growth, so you can stay ahead of the game in this changing industry.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...
PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...